Medicalgorithmics Reports Q1 2023 Results, Demonstrating Strategic Shift towards Software and Enhanced Balance Sheet Strength
Warsaw, Poland – May 30, 2023 – Medicalgorithmics, SA, a global healthcare technology company leveraging AI to revolutionize medical diagnostics worldwide, announced its financial results for the three months ended March 31, 2023. The company showcased significant, and better than expected progress in executing the new business plan adopted after the acquisition by BioFund of the 49.99% of the company at the end of Q4/2022, including (1) a strategic shift towards software and analytics monetization (resulting in improved growth prospects and strengthened liquidity), and (2) a strategic shift away from former reseller distribution agreements worldwide that used to involve regional exclusivity and impaired growth.